SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Precious metals surge amid economic uncertainty, outperforming retreating cryptos as safer investments in 2026. It's your time to stack some Digital $METALS

Digital Metals

METALS CRYPTO is trending due to widespread community discussion anticipating significant upward movement. Many users are actively promoting the digital asset, expressing a belief that it is on the verge of going parabolic and comparing its potential to other major cryptocurrencies.

Electro Optic Systems Holdings Ltd. develops and produces products incorporating advanced electro-optic technologies for the aerospace market. It operates through the Space Systems and Defence Systems segments. The Space Systems segment is involved in ground products available to support the Australian and international space markets. The Defence Systems segment develops, manufactures, and markets advanced fire control, surveillance, and weapon systems to approved military customers. The company was founded by Benny Allan Greene in 1983 and is headquartered in Symonston, Australia.

Electro Optic Systems Holdings Ltd

Electro Optic Systems Holdings Ltd. is generating significant buzz due to recent major contracts, including deals for remotely operated weapon stations with the US Army and a substantial laser system order. The company is a critical technology partner in the accelerated 'Golden Dome' US missile defense initiative, providing cutting-edge laser tracking and directed energy solutions. Community sentiment is overwhelmingly bullish, fueled by EOPSF's demonstrated superior performance in competitive counter-drone trials and its expanding portfolio in defense technologies.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending as investors digest a strong Q3 earnings beat against a backdrop of record-high precious metal prices, sparking intense debate over its valuation and near-term trajectory. While many in the community anticipate a "parabolic" rise for gold miners, others express frustration over the stock's volatility and perceived disconnect from the broader metal rally, especially following recent production outlook concerns.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is trending amid renewed analyst confidence and its critical role in the surging demand for high-performance memory, with recent upgrades and coverage initiations highlighting its strategic position. The community actively discusses RMBS as an undervalued "hidden gem" with a strong balance sheet, poised to benefit from its intellectual property licensing and growing product revenues crucial for AI and data center infrastructure.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is trending due to its expanding utility for Bitcoin (BTCFi) through staking and yield opportunities, alongside its launch on the Solana blockchain for enhanced interoperability. The community highlights its cutting-edge ZK-STARK technology for quantum resistance, native Account Abstraction for improved user experience, and significant growth in Total Value Locked and active users, positioning it as a leading Layer 2 solution.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

BeOne Medicines Ltd - ADR

BeiGene Ltd - ADR

BeOne Medicines (ONC) is trending as it cements its position as a global oncology powerhouse, marked by its recent name change and expanding regulatory successes. The company is generating significant conversation with new FDA and European approvals for therapies like Tevimbra in lung and gastric cancers, alongside a robust pipeline featuring advanced BTK degraders and bispecific antibodies. Community discussions highlight ONC's "speed-to-access" commercial strategy, growing market leadership, and the long-term potential of its diverse oncology portfolio.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as its Vevye drug gains significant market traction, notably securing a preferred position with a major PBM, sparking analyst upgrades and a Zacks "Strong Buy" rating. The community is actively discussing Vevye's substantial growth potential and the possibility of a short squeeze, propelling long-term bullish sentiment despite past concerns over guidance. With upcoming product launches and expanding market reach in ophthalmology, investors anticipate continued upside from its current valuation.

BYD Co., Ltd. engages in the research, development, manufacture, and sale of rechargeable batteries and photovoltaic business. It operates through the following segments: Rechargeable Batteries and Photovoltaic Products, Mobile Handset Components, Assembly Service and Other Products, and Automobiles and Related Products and Other Products. The Rechargeable Batteries and Photovoltaic Products segment is involved in the manufacture and sale of lithium-ion batteries and nickel batteries, photovoltaic products, and iron batteries products for mobile phones, electric tools, and other portable electronic instruments, photovoltaic products, energy storage products, and electric vehicles. The Mobile Handset Components, Assembly Service and Other Products segment focuses on the sale of mobile handset components such as housings, electronic components, assembly services, and medical protection products. The Automobiles and Related Products and Other Products segment consists of automobiles and auto-related moulds and components and automobile leasing and after sales services, rail transport related business, and medical protection products. The company was founded by Chuan Fu Wang on February 10, 1995 and is headquartered in Shenzhen, China.

BYD Co - Ordinary Shares - Class H

BYD Co

BYD Co. is commanding attention as it continues to outperform rivals like Tesla in global EV sales and revenue, driven by its advanced battery technology and competitive pricing strategy. The community is buzzing about BYD's aggressive international expansion, particularly in Europe and Asia, which is solidifying its market leadership and bolstering its competitive edge despite broader geopolitical considerations.

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Quantum BioPharma Ltd

Quantum BioPharma is trending due to its high-profile $700 million lawsuit against major Canadian banks for alleged stock manipulation, a narrative amplified by recent media exposure and comparisons to other contested equities. While this legal action sparks optimism among some for a potential short squeeze, a strong counter-narrative within the community expresses deep skepticism over the company's operational history, including past dilutions and unfulfilled project milestones.

Las Vegas Sands Corp. engages in the development of destination properties. It operates through the Macao and Singapore geographical segments. The Macao segment handles the operations of The Venetian Macao, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Macao, and Sands Macao. The Singapore segment includes the Marina Bay Sands. The company was founded by Sheldon Gary Adelson in August 2004 and is headquartered in Las Vegas, NV.

Las Vegas Sands Corp

Las Vegas Sands (LVS) is trending due to recent strong earnings performance, particularly from its Singapore operations, and a continued recovery in Macau gaming revenue. This positive momentum has led to multiple analyst upgrades and renewed investor confidence, positioning LVS as a favored name within the integrated resort sector. The community is actively discussing its strategic focus on high-growth Asian markets and significant shareholder return initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
